Ameritas Investment Partners’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Ameritas Investment Partners’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,195	Closed	-$22K	–	3127
2021 Q4	$22K	Hold	7,195	–	–	﹤0.01%	2615
2021 Q3	$26K	Hold	7,195	–	–	﹤0.01%	2571
2021 Q2	$26K	Hold	7,195	–	–	﹤0.01%	2610
2021 Q1	$28K	Hold	7,195	–	–	﹤0.01%	2419
2020 Q4	$30K	Hold	7,195	–	–	﹤0.01%	2288
2020 Q3	$27K	Hold	7,195	–	–	﹤0.01%	2224
2020 Q2	$31K	Hold	7,195	–	–	﹤0.01%	2126
2020 Q1	$27K	Hold	7,195	–	–	﹤0.01%	2021
2019 Q4	$45K	Hold	7,195	–	–	﹤0.01%	1992
2019 Q3	$30K	Hold	7,195	–	–	﹤0.01%	2182
2019 Q2	$33K	Buy	+7,195	New	+$33.5K	﹤0.01%	2161

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

Ameritas Investment Partners's BDSI Position: Q1 2022 in Review

Ameritas Investment Partners sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 7,195 shares — an estimated $22K sold.

Ameritas Investment Partners first reported a position in BDSI in Q2 2019 and held it in 11 quarters. The position peaked at $45K in Q4 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

Ameritas Investment Partners reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
Ameritas Investment Partners sold 7,195 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $22K.
Ameritas Investment Partners first reported a position in BioDelivery Sciences International, Inc. in Q2 2019 and held it in 11 quarters.
Ameritas Investment Partners's BioDelivery Sciences International, Inc. position peaked at $45K in Q4 2019.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Ameritas Investment Partners's 13F filing for Q1 2022, filed 13 May 2022.